Testing effectiveness (Phase 2)Study completedNCT00027716
What this trial is testing
Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma
Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center
Showing 20 of 0 results